Question · asked by 1 review
FLUPHENAZINE DECANAOTE vs FLUPHENAZINE ENANTHATE: Leaving the study early
- Population
- patients with schizophrenia
- Intervention
- FLUPHENAZINE DECANAOTE
- Comparison
- FLUPHENAZINE ENANTHATE
- Outcome
- Leaving the study early
It is very uncertain whether FLUPHENAZINE DECANAOTE changes leaving the study early compared with FLUPHENAZINE ENANTHATE (very low certainty).
What each review found
Include earlier review versions| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
FLUPHENAZINE DECANAOTE vs FLUPHENAZINE ENANTHATE Leaving the study early · patients with schizophrenia It is very uncertain whether FLUPHENAZINE DECANAOTE changes leaving the study early compared with FLUPHENAZINE ENANTHATE (very low certainty). Fluphenazine decanoate (depot) and enanthate for schizophrenia (2015) · Cochrane Headline outcomes only | RR 2.43 [0.71, 8.32] | 1 study · 49 participants | Very low |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Fluphenazine decanoate (depot) and enanthate for schizophrenia 2015 · Cochrane Headline outcomes only | Not reported | Not extracted | Not assessed |
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.